Skip to main content

Peer Review reports

From: Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR

Original Submission
22 Dec 2021 Submitted Original manuscript
6 Jan 2022 Reviewed Reviewer Report
7 Jan 2022 Reviewed Reviewer Report
5 Feb 2022 Author responded Author comments - Takayuki Ueno
Resubmission - Version 2
5 Feb 2022 Submitted Manuscript version 2
15 Feb 2022 Reviewed Reviewer Report
18 Feb 2022 Reviewed Reviewer Report
7 Mar 2022 Author responded Author comments - Takayuki Ueno
Resubmission - Version 3
7 Mar 2022 Submitted Manuscript version 3
Publishing
10 Mar 2022 Editorially accepted
25 Apr 2022 Article published 10.1186/s12916-022-02332-1

You can find further information about peer review here.

Back to article page